Search

Your search keyword '"Violini, Roberto"' showing total 311 results

Search Constraints

Start Over You searched for: Author "Violini, Roberto" Remove constraint Author: "Violini, Roberto"
311 results on '"Violini, Roberto"'

Search Results

1. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

2. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

3. Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction

4. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

5. Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction

6. Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO‐3 randomized trial

7. Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison

8. Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: Insights from the DESERT cooperation

9. Effect of valve design and anticoagulation strategy on 30‐day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial

11. Impact of Age on Long-Term Outcome After Primary Angioplasty With Bare-Metal or Drug-Eluting Stent (from the DESERT Cooperation)

12. Meta-Analysis Comparing Efficacy and Safety of First Generation Drug-Eluting Stents to Bare-Metal Stents in Patients With Diabetes Mellitus Undergoing Primary Percutaneous Coronary Intervention

14. IMPACT OF CORONARY ARTERY DISEASE ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL

15. IMPACT OF CHRONIC THROMBOCYTOPENIA ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL

18. Drug-eluting stents in patients with anterior STEMI undergoing primary angioplasty: a substudy of the DESERT cooperation

19. Scientific Foundation and Possible Implications for Practice of the Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of AngioX (MATRIX) Trial

22. Stents liberadores de fármacos frente a stents convencionales en pacientes diabéticos con infarto agudo de miocardio con elevación del segmento ST: un análisis combinado de los datos de pacientes individuales de 7 ensayos aleatorizados

23. Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From 7 Randomized Trials

26. Position paper GISE (Società Italiana di Cardiologia Interventistica): ricovero breve per la PCI in elezione, uno strumento per la 'ripartenza'

27. Impact of anemia on short‐term outcomes after TAVR : A subgroup analysis from the BRAVO ‐3 randomized trial

31. Impact of Chronic Kidney Disease on Periprocedural Anticoagulation and Short-Term Outcomes after TAVR: A BRAVO-3 Trial Subanalysis

34. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

36. Management of patients with patent foramen ovale and cryptogenic stroke: A Collaborative, Multidisciplinary, Position Paper: Executive Summary

37. Impact of Diabetes on Long-Term Outcome After Primary Angioplasty: Insights from the DESERT cooperation

40. Drug-Eluting vs Bare-Metal Stents in Primary Angioplasty: A Pooled Patient-Level Meta-analysis of Randomized Trials

41. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis

43. Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial

44. Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial

45. TCT-803 Clinical Outcomes After TAVR in Patients With and Without Peripheral Arterial Disease: Results From the BRAVO-3 Randomized Trial

46. [Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation]

47. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

48. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

49. Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

50. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction

Catalog

Books, media, physical & digital resources